The Latest Clinical Study on GLP-1 Receptor Agonists

from Redox Revolution · host William Seeds, MD

In this podcast, Dr. Seeds addresses a recent clinical study that advances the effectiveness of GLP-1 receptor agonists like semaglutide (trade name Ozempic) as an anti-aging treatment. Follow for more!Instagram: @williamseedsmd | @redoxmedicalgroupYoutube: Subscribe Here

Episode metadata supplied by the publisher feed · Published Sep 23, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

The Latest Clinical Study on GLP-1 Receptor Agonists

0:00 38:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Redox Revolution?

This episode is 38 minutes long.

When was this Redox Revolution episode published?

This episode was published on September 23, 2025.

Can I download this Redox Revolution episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!